The cost of universal free access for treating HIV/AIDS in low-income countries: The case of Senegal

The Political Economy of HIV/AIDS in Developing Countries: TRIPS, Public Health Systems and Free Access

Volumn , Issue , 2008, Pages 273-290

  Taverne, Bernard ^b   Diop, Karim ^a   Vinard, Philippe ^b  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85020663715     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4337/9781848444898.00024     Document Type: Chapter

References (19)

1. Braitstein, P., M.W.G. Brinkhof, F. Dabis et al. (2006), 'Mortality of HIV-1- Infected Patients in the First Year of Antiretroviral Therapy: Comparison between Low-Income and High-Income Countries, Lancet, 367: 817-24.
2. Canestri, A., B. Taverne, S. Thiam et al. (2004), 'Direct, Extra-ARV Medical Follow-Up Costs for Patients', in A. Desclaux, I. Ndoye, I. Lanièce and B. Taverne (eds), The Senegalese Antiretroviral Drug Access Initiative. An Economic, Social, Behavioural and Biomedical Analysis, ANRS, UNAIDS, WHO, pp. 49-59.
3. CNLS (2001), Plan stratégique 2002-2006 de lutte contre le sida, République du Sénégal: Conseil National de Lutte contre le Sida.
4. Desclaux, A, I. Lanièce, I. Ndoye and B. Taverne (eds) (2004), The Senegalese Antiretroviral Drug Access Initiative. An Economic, Social, Behavioural and Biomedical Analysis, Paris: ANRS, UNAIDS, WHO.
5. Etard, J.F., I. Ndiaye, M. Thierry et al. (2006), 'Mortality and Causes of Death in Adults Receiving Highly Active Antiretroviral Therapy in Senegal: A 7-Year Cohort Study', AIDS, 20(8): 1181-89.
6. Gilks, C.F., S. Crowley, R. Ekpini et al. (2006), 'The WHO Public-Health Approach to Antiretroviral Treatment against HIV in Resource-Limited Settings', Lancet, 368: 505-10.
7. Gomes (do E.S.), E. (2000), 'Étude sur l'équité dans l'accès aux soins de santé et les déterminants socio-économiques des recours aux soins dans la région de Dakar', Ministère de la Santé, FNUAP, Service de coopération et d'action culturelle.
8. Laguide, R., N. Elengua, P. Fassinou et al. (2003), 'Direct Costs of Medical Care for HIV-Infected Children before and during HAART in Abidjan, Côte d'Ivoire, 2000-2003', in J.-P. Moatti, B. Coriat, Y Souteyrand et al. (eds), Economics of AIDS and Access to HIV/AIDS Care in Developing Countries. Issues and Challenges, Paris: ANRS, pp. 311-27.
9. Lanièce, I., M. Ciss, A. Desclaux et al. (2003), Adherence to HAART and its Principal Determinants in a Cohort of Senegalese Adults', AIDS, 17(suppl. 3): S103-S108.
10. McIntyre, D., M. Thiede, G. Dahlgren and M. Whitehead (2006), 'What are the Economic Consequences for Households of Illness and of Paying for Health Care in Low- and Middle-Income Country Contexts?' Social Science and Medicine, 62(4): 858-65.
11. Meda, N., I. Ndoye, S. M'Boup et al. (1999), 'Low and Stable HIV Infection Rates in Senegal: Natural Course of the Epidemic or Evidence for Success of Prevention?' AIDS, 13(11): 1397-405.
12. Meessen, B., W Van Damme, C. Tashobyas and A. Tibouti (2006), 'Poverty and User Fees for Public Health Care in Low-Income Countries: Lessons from Uganda and Cambodia', Lancet, 368: 2253-7.
13. MSPM (2005), Prise en charge médicale des patients vivant avec le VIH/sida au Sénégal, Dakar: Ministère de la Santé et de la Prévention Médicale, CNLS.
14. MSPM (2006), 'Données Epidémiologiques du VIH/sida au Sénégal, 2004-2005', République du Sénégal, Conseil National de Lutte Contre le Sida, Ministère de la Santé et de la Prévention Médicale, Division de Lutte Contre le Sida/IST, Laboratoire de Bactériologie et de Virologie, C.H.U. A. Le Dantec, Dakar- Sénégal.
15. Nabyonga, J., M. Desmet, H. Karamagi et al. (2005), 'Abolition of Cost-Sharing is Pro-Poor: Evidence from Uganda', Health Policy and Planning, 20(2): 100-108.
16. Vinard, P, M. Ciss, B. Taverne, A. Ly and I. Ndoye (2003), Analysis of HIV/AIDS Expenditures in Senegal: From Pilot Project to National Program, in J. Moatti et al. (eds), Economics of AIDS and Access to HIV/AIDS Care in Developing Countries: Issues and Challenges, Paris: ANRS, pp. 459-82.
17. Whiteside, A. and S. Lee (2005), 'The "Free by 5" Campaign for Universal, Free Antiretroviral Therapy', PLoS Med, 2(8): e227.
18. WHO (2005), 'The Practice of Charging User Fees at the Point of Service Delivery for HIV/AIDS Treatment and Care', WHO Discussion Paper, WHO/HIV/- 2005.11.4.
19. WHO (2006), 'Progress on Global Access to HIV Antiretroviral Therapy: a Report on "3 by 5" and Beyond', WHO.